Nanofiber-Based Delivery of Therapeutic Peptides to the Brain
Citations Over TimeTop 10% of 2013 papers
Abstract
The delivery of therapeutic peptides and proteins to the central nervous system is the biggest challenge when developing effective neuropharmaceuticals. The central issue is that the blood-brain barrier is impermeable to most molecules. Here we demonstrate the concept of employing an amphiphilic derivative of a peptide to deliver the peptide into the brain. The key to success is that the amphiphilic peptide should by design self-assemble into nanofibers wherein the active peptide epitope is tightly wrapped around the nanofiber core. The nanofiber form appears to protect the amphiphilic peptide from degradation while in the plasma, and the amphiphilic nature of the peptide promotes its transport across the blood-brain barrier. Therapeutic brain levels of the amphiphilic peptide are achieved with this strategy, compared with the absence of detectable peptide in the brain and the consequent lack of a therapeutic response when the underivatized peptide is administered.
Related Papers
- → Immortalized Human Brain Endothelial Cell Line HCMEC/D3 as a Model of the Blood-Brain Barrier Facilitates In Vitro Studies of Central Nervous System Infection by Cryptococcus neoformans(2009)125 cited
- → Self-assembly of Peptide Amphiphiles with Alkyl Groups for siRNA Delivery(2023)2 cited
- → Interleukin-10 as a CNS therapeutic: the obstacle of the blood–brain/blood–spinal cord barrier(2003)48 cited
- → Controlled disassembly of peptide amphiphile fibres(2007)16 cited
- → Blood-Brain Barrier and Exercise – a Short Review(2008)8 cited